glp 1/gip receptor agonist Schematic illustration of monoagonists, dual agonists and triple Mechanisms of action of GLP-1

Explore the implications of proposed changes to GLP-1 medication coverage and their impact on Medicare and Medicaid health plans

However, owing to their peptide-based composition, GLP-1RAs have traditionally required injectable administration, which undermines patient adherence, convenience, and long-term accessibility

These drugs have recently become more comm

Current evidence on drug transfer into breast milk is limited for most compounds, making provider consultation essential before starting or continuing treatment during lactation

GLP-1 agonist is a class of medications that are used in type 2 diabetes and obesity